about
Topical emollient for preventing infection in preterm infantsInterventions to prevent hypothermia at birth in preterm and/or low birthweight infantsTraditional massage of newborns in Nepal: implications for trials of improved practiceThe infant skin barrier: can we preserve, protect, and enhance the barrier?Newborn boys and girls differ in the lipid composition of vernix caseosaClinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.Topical ointment for preventing infection in preterm infants.Skin hygiene and infection prevention: more of the same or different approaches?Emollient ointment for preventing infection in preterm infants.Epidermal barrier treatments based on vernix caseosa.Malnutrition-associated rash of cystic fibrosis.The effect of daily treatment with an olive oil/lanolin emollient on skin integrity in preterm infants: a randomized controlled trial.Unraveling the mystery of vernix caseosaA pilot study of emollient therapy for the primary prevention of atopic dermatitisCaring for and protecting the skin of pre-term neonates.Tolerance of skin care regimen in healthy, full-term neonates.Tolerance of natural baby skin-care products on healthy, full-term infants and toddlers.Corneobiology and corneotherapy--a final chapter.Children and newborn skin care and prevention.Barrier-restoring therapies in atopic dermatitis: current approaches and future perspectivesTopical Oil Application and Trans-Epidermal Water Loss in Preterm Very Low Birth Weight Infants-A Randomized Trial.The effect of topical ointment on neonatal sepsis in preterm infants.Orally administered ethanol: transepidermal pathways and effects on the human skin barrier.Improved outcome of extremely low birth weight infants with Tegaderm application to skin.Randomized trial of sterile water by gavage drip in the fluid management of extremely low birth weight infants.Effectiveness of No-Sting skin protectant and Aquaphor on water loss and skin integrity in premature infants.Routine skin cultures in predicting sepsis pathogens among hospitalized preterm neonates in Bangladesh.
P2860
Q24186317-B3BB1FCE-035C-419B-A905-5CAD998C92BBQ24236569-43BA6FAD-8484-4107-8132-203AF577FE29Q24535461-0EFAD859-AD18-4FFD-A44D-E3DEE25DF372Q28275320-955A2E76-E0D1-46AA-B8F6-9A20C9731AB8Q28539514-068689E2-E77C-43A6-BE6C-96E1845F0ED9Q30433993-1622C327-CCD3-46ED-884E-651FDA4BDE17Q31048823-145CC6A7-EC67-4F88-81DA-714548AA494FQ33753414-268E1F1D-8A69-4D98-8D9A-FB5A7318625CQ33907407-B8425EF8-6253-4AA3-A804-1E452CE8448AQ33984702-49C5CCB7-2CC6-420E-B357-9769E4942F94Q34086280-023E61CF-25D4-4E32-9E4C-2EE71B031557Q34772828-391EC33A-2CE1-4D07-AC67-A2A02910CB74Q35010870-7F353F3F-C977-48F9-9A4A-3B95B2811AA0Q35166369-4628F464-2106-4DA1-AC97-EB9DD8D94C9BQ35215323-648301AC-05B1-4230-BB5A-48ABE5B1BBDDQ36905806-F0CC8726-FD81-4A28-8A0C-A02BE0FCFA09Q37577746-89B2276F-033A-42AA-B39E-54C18ACA9BC3Q37850463-C5C10555-2249-432A-941A-0E9BCDF40AE9Q37857733-B9E5FC24-0B3A-497D-AC85-9C8B394A2A9AQ39556853-F7319CDC-DF4A-42B3-8F8C-4F1A560A33D7Q41016296-6120F04C-C159-4F28-978D-707E2ED82071Q44360081-EC0896A2-6E3B-496C-AAF1-FAC8CB5A8465Q45224278-C56512D2-7F6D-4FB3-B624-A72866B80236Q46345048-BDAE5513-AC9F-4A24-8FD3-51E1A1FF5222Q46406558-EB39E996-F176-4251-A5C4-B5F9F2BCD14EQ46982049-FF97A69A-CEE8-4C2B-AF58-E2BF6622CC75Q50063550-A06370C7-06FC-46EF-A2E2-692B6BF82229
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Topical ointment therapy benefits premature infants.
@en
Topical ointment therapy benefits premature infants.
@nl
type
label
Topical ointment therapy benefits premature infants.
@en
Topical ointment therapy benefits premature infants.
@nl
prefLabel
Topical ointment therapy benefits premature infants.
@en
Topical ointment therapy benefits premature infants.
@nl
P2093
P1476
Topical ointment therapy benefits premature infants.
@en
P2093
P304
P356
10.1016/S0022-3476(96)80132-6
P407
P433
P577
1996-05-01T00:00:00Z